XARELTO (rivaroxaban) for Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Printer-friendly versionPrinter-friendly version
State: 
TX
Chapter: 
Date: 
11/29/2012 - 6:30pm - 9:00pm


Speaker:
David Smith, MD, FAAFP, CMD
President, Geriatric Consultants of Central Texas, PA
Brownwood, TX
Dr. Smith is a paid speaker for Janssen Pharmaceuticals, Inc.

Perry's Steakhouse
9730 Cypresswood Drive
Houston, TX 77070

Sponsored by Janssen Pharmaceuticals, Inc.

User login

MEMBER LOGIN

To prevent automated spam submissions leave this field empty.
Become a Member Today ASCP